Fukuda Sangyo Model SpiroAnalyzer ST-180
by Spirosoft Northamerica, Inc.
510(k) K943546
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK943546 | Date23 Feb 1995 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- BZG
- Device Class
- Class II
- Regulation
- 21 CFR Part 868.1840
- Advisory Committee
- Anesthesiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The Fukuda Sangyo Model SpiroAnalyzer ST-180 is a diagnostic spirometer, a device used to measure lung function by assessing airflow and lung volumes. It evaluates respiratory health by generating spirometry readings, including forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and peak expiratory flow (PEF), aiding in the diagnosis and monitoring of pulmonary conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders.
This device is intended for use in clinical settings, including anesthesia and respiratory care environments, where precise lung function assessment is required. Supplied as a reusable medical instrument, it adheres to regulatory standards under FDA classification II (BZG) and is authorized under the 510(k) clearance process (K943546). The SpiroAnalyzer ST-180 operates under the regulatory framework of 21 CFR 868.1840, ensuring compliance with diagnostic medical device requirements. No specific sterility or MRI safety information is provided in the available data.